1. Creppy,E. Chiarappa,P.; Baudrimont,I.; Borracci,P.; Moukha,M. S.; Carratu (2004). Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicol.2004, 201, 15-123.
2. P. Njobeh,M. Dutton,A. Makun (2010). H Mycotoxins and human health: Significance, prevention and control In: Mishra AK, Tiwari A, Mishra SB and Kobayashi H (Eds), Smart Biomolecules in Medicine. Smart Biomolecules in Medicine, 2010, 132-177.
3. S. Hussein,M. Brasel (2001). Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology, 167(2), 101-134.
4. William,P.; Jolly,E.; Ellis,W. Gyawu,E.; Johnson,N. Robinson,T. AG.; Phillips (2010). HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub-Saharan Africa. Nutr,2010, 92, 154-160.
5. Paul Turner,Sophie Moore,Andrew Hall,Andrew Prentice,Christopher Wild (2003). Modification of immune function through exposure to dietary aflatoxin in Gambian children Environ. Environmental Health Perspectives, 111(2), 217-220.
6. Gong,Y. Hounsa,A.; Egal,S.; Turner,P. Sutcliffe,A. Cardwell,C. K.; Wild (2004). Post-weaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa Environ. Health Perspect.2004, 112, 1334-1338.
7. Williams Phillips,T. Jolly,P. Stiles,J. Jolly,D. C.M.; Aggarwal (2004). Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences and interventions Am J Clin. Nutr.2004, 80, 1106-1122.
8. J. Wagacha,J. Muthomi (2008). Mycotoxin problem in Africa current status implications to food safety and health and possible management strategies Inter J. International Journal of Food Microbiology, 124(1), 1-12.
9. R. Riley (1998). Mechanistic interactions of mycotoxins: theoretical consideration In: Sinha, K.K., Bhatnagar, D (Eds.), Mycotoxins in Agriculture and Food Safety. Mycotoxins in Agriculture and Food Safety, 1998, 227-254.
10. Yoo,H. Norred,Riley W.P.; Showker (1996). R.T.Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.Toxicol& Appl. Pharmacol.1996, 138, 211-218.
11. A. Merrill (1997). Jr.; Schmelz, E.M.; Dillehay, D.L.; Spiegel, S.; Shayman, J.A.; Schroeder, J.J.; Riley, R.T.; Voss, K.A.; Wang, E Sphingolipids: The enigmatic lipid class: Biochemistry, Physiology and Pathophysiology Toxicol Appl. Pharmacol, 142, 208-225.
12. G. Shephard,L. Van der Westhuizen (1998). Liquid chromatographic determination of the sphinganine/sphingosine ratio in serum. Chromat B, 710, 219-222.
13. W. Marasas,K. Jaskiewics,F. Venter,D. VanSchalkwyk (1988). Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei S A Med J. S. A. Med. J, 74, 110-114.
14. G. Diaz,H. Boermans (1994). Boermans, H.J., Fumonisin toxicosis in domestic animals: a review Vet. Vet. Human Toxicol, 36, 548-555.
15. Ueno,Y.; Lijima,K.; D-Wang,S. Sugiura,Y.; Sekijima,T.; Tanaka,T.; Chen,S. C.; Yu (1997). Fumonisins as a possible contributory risk factor for primary liver cancer: A 3-year study of corn harvested in Haimen, China, by HPLC and ELISA Food Chem. Toxicol.1997, 35, 1143-1150.
16. J. Fincham,W. Marasas,J. Taljaard,N. Kriek,C. Badenhorst,W. Gelderblom,J. Seier,C. Smuts,M. Faber,M. Weight (1992). Atherogenic effects in a non-human primate of cultures added to a carbohydrate diet. Atherosclerosis, 94(1), 13-25.
17. Michael Dutton (2009). The African Fusarium/maize disease.Mycotox Res. Mycotoxin Research, 25(1), 29-39.
18.
19. Janee Gelineau‐van Waes,Lois Starr,Joyce Maddox,Francisco Aleman,Kenneth Voss,Justin Wilberding,Ronald Riley (2005). Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model Birth Defects Research A: Clin Mol. Teratol.2005, 73(7), 487-497.
20. Stacey Missmer,Lucina Suarez,Marilyn Felkner,Elaine Wang,Alfred Merrill,Kenneth Rothman,Katherine Hendricks (2006). Exposure to fumonisins and the occurrence of neural tube defects along the Texas–Mexico border Environ. Environmental Health Perspectives, 114(2), 237-241.
21. G. Devegowda,M. Radu,A. Nazar,H. Swamy (2000). Mycotoxin picture worldwide: Novel solutions for their counteraction. Proceedings of Alltech’s 14th Annual Symposium
22. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Monograph, 82
23. Lillerberg,S. Cabonce,M. Raju,N. Wagner,L. L.M.; Kier (1992). Alterations in the p53 tumour suppressor gene in rat liver tumours induced by aflatoxin B1 Program.Clin Biol. Res.1992, 376, 203-222.
24. Aguilar,F.; Hussdain,P. S.P.; Cerutti (1993). Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Sci, 1993, 8586-8590.
25. Y. Gong,S. Egal,A. Hounsa,P. Turner,A. Hall,K. Cardwell,C. Wild (2003). Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning Food Res. Intern.2003, 37, 985-1000.
26. (1993). Monographs on the evaluation of the carcinogenic risk of chemicals to human: Some naturally occurring substances. Food items and constituents, heterocyclic aromatic amines and mycotoxins.
27. E. Creppy (1983). Comparative study of the effect of ochratoxin A analogues on yeast aminoacyltRNAsynthetases and on the growth and protein synthesis of hepatoma cells Toxicol. Toxicology Letters, 19(3), 217-224.
28. R. Manderville (2007). Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutrit. Food Res, 51, 61-99.
29. Evaluation of Certain Mycotoxins in Food. Joint Expert Committee on Food Additives (JECFA
30. P. Mantle,V. Faucer-Marquis,R. Manderville,B. Squillaci (2010). Pfohl-Leszkowicz, A., Structures of covalent adducts between DNA and ochratoxin A: a new factor in debate about genotoxicity and human risk assessment Chem Res.Toxicol. Chemical Research in Toxicology, 23(1), 89-98.
31. Stoev,S. etiology,prophylaxis,humans (2008). Complex Etiology, Prophylaxis and Hygiene Control in Mycotoxic Nephropathies in Farm Animals and Humans. Sc.2008b, 9, 578-605.
32. Stoev,S. Denev,S.; Njobeh,P. Mosonik,J. Steenkamp,P. Petkov (2010). Complex etiology and pathology of mycotoxic nephropathy in South African pigs. Res.2010, 10, 31-46.
33. S. Stoev (2008). Mycotoxic nephropathies in farm animals’ diagnostics, risk assessment and preventive measures.
34. J. Fink‐gremmels,L. Leistner (1990). Toxicological evaluation of moulds. Food Biotechnology, 4(1), 579-584.
35. S. Stoev,S. Denev,M. Dutton,B. Nkosi (2009). Cytotoxic Effect of Some Mycotoxins and their Combinations on Human Peripheral Blood Mononuclear Cells as Measured by the MTT Assay Toxinol J. The Open Toxinology Journal, 2(1), 1-8.
36. Mwanza,M.; Kametler,L.; Bonais,A.; Rajli,M. V.; Kovacs,M. Dutton (2009). The cytotoxic effect of fumonisin B1 and ochratoxin A on human and pig lymphocytes using the Methyl Thiazol Tetrazolium (MTT) assay. Res.2009, 25, 233-238.
37. F. Meky,L. Hardie,S. Evans,C. Wild (2001). Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production Food Chem Toxicol. Food and Chemical Toxicology, 39(8), 827-836.
38. Narendra Singh,Michael McCoy,Raymond Tice,Edward Schneider (1988). A simple technique for quantitation of low levels of DNA damage in individual cells.Experiment Cell Res. Experimental Cell Research, 175(1), 184-191.
39. Collins,A. Oscoz,A. Brunborg,G.; Gaivao,I.; Giovannelli,L.; K (1997). The comet assay: topical issues. Mutagenesis, 23(3), 143-151.
40. A. Hartmann,E. Agurell,C. Beevers,S. Brendler- Schwaab,B. Burlinson,P. Clay (2003). Clay, P., 2003: Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis, 18(1), 45-51.
41. P. Delves,Seamus M.,D. Burton,Y. Roitt (2006). Roitt's essential immunology.
42. K. Charoenpornsook,J. Fitzpatrick,J. Smith (1998). The effects of four mycotoxins on the mitogen stimulated proliferation of bovine peripheral blood mononuclear cells in vitro. Mycopathologia, 143(2), 105-111.
43. Mary Dombrink-Kurtzman,Tariq Javed,Glenn Bennett,John Richard,L. Cote,William Buck (1993). Lymphocyte cytotoxicity and erythrocytic abnormalities induced in broiler chicks by fumonisins B1 and B2 and moniliformin from Fusarium proliferatum. Mycopathologia, 124(1), 47-54.
44. Grabsch,G.; Wichmann,G.; Loffhagen,H.; Herbarth,A. O.; Muller (2006). Cytotoxicity assessment of gliotoxin and penicillic acid in Tetrahymenapyriformis, Environ. Toxicol.2006, 2, 111-117.
45. C. Lewis,J. Smith,J. Anderson,R. Freshney (1999). Increased cytotoxicity of food-borne mycotoxins toward human cell lines in vitro via enhanced cytochrome p450 expression using the MTT bioassay. via enhanced cytochrome p450 expression using the MTT bioassay. Mycopathol.1999, 148, 97-102.
46. J. Timbrell (2001). Toxic responses to foreign compounds In Principles of Biochemical Toxicology, 3rd ed. Principles of Biochemical Toxicology, 2001, 240-247.
47. F. Kiechle (2004). The omics era and its impact. Arch. Pathol. Lab Med, 128, 1337-1345.
48. D. Vinatier,P. Dufour,D. Subtil (1996). Apoptosis: a programmed cell death involved in ovarian and uterine physiology European J Obstetric Gynaecol Repro Biol. European Journal of Obstetrics & Gynecology and Reproductive Biology, 67(2), 85-102.
49. Domijan,A.; Zeljezic,D.; Kopjar,M. N.; Peraica (2006). Standard and Fpg-modified comet assay in kidney cells of ochratoxin Aand fumonisin B1-treated rats. Toxicology, 222(1-2), 53-59.
50. Peter Lutz,Liscia Manuel (1999). Maintenance of adenosine A1receptor function during long-term anoxia in the turtle brain. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 276(3), R633-R636.
51. Mário Mantovani,Marilanda Bellini,José Angeli,Rodrigo Oliveira,Ariane Silva,Lúcia Ribeiro (2008). β-Glucans in promoting health: Prevention against mutation and cancer Mutation Res. Mutation Research/Reviews in Mutation Research, 658(3), 154-161.
52. F. Minervini,F. Fornelli,K. Flynn (2004). Toxicity and apoptosis induced by the mycotoxins nivalenol, deoxynivalenol and fumonisin B1 in a human erythroleukemia cell line. Toxicology in Vitro, 18(1), 21-28.
53. M. Theumer (2003). Immunobiological effects of AFB1 and AFB1–FB1 mixture in experimental subchronic mycotoxicoses in rats. Toxicology, 186(1-2), 159-170.
54. W. Butler,G. Neal (1977). Mode of action and human health aspects of aflatoxin carcinogenesis.
55. E. Lillehoj (1991). Aflatoxin: an ecologically elicited activation signal. Mycotoxins and Animal Foods, 1991, 119-139.
56. L. Foster,K. Kozack,M. Loftus (1993). Steven, J., The polymerase chain reaction and its application to filamentous fungi. Mycological Research, 97(7), 769-781.
57. Raney,K. Meyer,D. Ketterer,B.; Harris,F. T.M.; Guengerish (1992). Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Toxicol.1992, 5, 470-478.
58. Yau-Huei Wei,Ching-Yow Lu,Teng-Nan Lin,Ru-Dong Wei (1985). Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology, 36(2-3), 119-130.
59. C. Wild,P. Turner The toxicology of aflatoxins as a basis for public health decisions.
60. Voss,K. Howard,P. Riley,R. Bucci,T. Lorentzen (2002). R.J Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (=F verticillioides) Cancer Detection Prev. Cancer Detection and Prevention, 26(1), 1-9.
61. W. Seefelder (2003). Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites Toxicol Appl. Pharmacol.2003, 192, 146-153.
62. CAST (2003). Mycotoxins: Risks in Plant, Animal, and Human Systems.
63. E. Wang,W. Norred,C. Bacon,R. Riley,A. Merrill (1998). Merrill, A.H Jr Inhibition of sphingolipids biosynthesis by fumonisin J Biol. Chem.1998, 273, 1025-1103.
64. G. Bondy,J. Pestka (2000). Immunomodulation by fungal toxins Environ. Environ. Health 3B, 2000, 109-143.
65. Martynova (2005). Fumonisin B1 modulates sphingomyelin cycle product levels and the expression of CD3 receptors in immunocompetent organs. Effects of mycotoxins on antioxidant status and immunity; InThe Mycotoxin Blue Book, 2005, 93-137.
